| 000 | 01360 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517181820.0 | ||
| 264 | 0 | _c20180806 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a1879-0712 | ||
| 024 | 7 |
_a10.1016/j.ejphar.2017.10.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChan, Hugh H | |
| 245 | 0 | 0 |
_aA novel selective MAO-B inhibitor with neuroprotective and anti-Parkinsonian properties. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cJan 2018 |
||
| 300 |
_a254-262 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xdrug effects |
| 650 | 0 | 4 |
_aImidazoles _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 |
_aMonoamine Oxidase _xchemistry |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xmetabolism |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xmetabolism |
| 650 | 0 | 4 |
_aParkinsonian Disorders _xdrug therapy |
| 650 | 0 | 4 | _aProtein Conformation |
| 700 | 1 | _aTse, Man Kit | |
| 700 | 1 | _aKumar, Saravana | |
| 700 | 1 | _aZhuo, Lang | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 818 _gp. 254-262 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2017.10.023 _zAvailable from publisher's website |
| 999 |
_c27703372 _d27703372 |
||